{
  "id": 9818462,
  "title": "Oura’s IPO Puts AI-Powered Healthcare on the Ticker",
  "url": "https://urgent.news/2026/09/25/ouras-ipo-puts-ai-powered-healthcare-on-the-ticker",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-25T19:25:29.000Z",
  "source": {
    "name": "PYMNTS",
    "slug": "pymnts",
    "url": "https://www.pymnts.com/healthcare/2026/ouras-ipo-puts-ai-powered-healthcare-on-the-ticker/"
  },
  "original_language": "en",
  "account": "Oura, a company renowned for its smart ring, is set to launch an initial public offering (IPO) on Nasdaq next week. The company has expanded its offerings beyond the ring, utilizing the data it collects on sleep, heart rate, temperature, and stress to provide personalized health guidance. Most recently, in February, Oura introduced an AI model that turned these signals into answers through its Oura Advisor chatbot, addressing women's health inquiries from menstrual cycles through menopause.\n\nThe ring has been instrumental in driving revenue, with growth of 74% to $1.21 billion over the nine months ending June 30, as reported by Reuters. The company's roadshow aims for a fully diluted valuation of $15.62 billion. Subscription revenue surged 121% to $240.5 million in the same period, and the firm anticipates reaching approximately 5.7 million paid members by fiscal 2026, a 96% increase from the previous year. This subscription service boasts an 89% gross margin.\n\nThe data generated by the ring becomes a monthly subscription service, while the hardware's sales are a one-time event. Eli Lilly, which collaborates with Oura on connected care, has shown interest in purchasing up to $100 million of the offering, according to Reuters.\n\nTraditionally, members interacted with the ring's data through scores and charts, but AI has transformed how the company monetizes this information. The company's AI model allows its chatbot to provide insights into various aspects of women's health, utilizing member's biometric data pulled directly from the ring. This model is developed internally and runs on Oura-controlled infrastructure to ensure privacy and confidentiality. The chatbot operates without diagnosing or prescribing treatments, and the ring remains a non-medical device.\n\nRicky Bloomfield, Oura's chief medical officer, emphasizes the complexity of women's health and the need for more personalized approaches. The chatbot, accessible through an opt-in feature within the app, is designed to refine member feedback before a wider release. This approach allows for a more comprehensive understanding of health patterns directly from the wearable, standing in contrast to general-purpose AI such as OpenAI's ChatGPT, which relies on external data sources and may miss valuable contextual information.",
  "summary": "https://www.samsung.com/us/Oura is preparing to launch an initial public offering (IPO) on Nasdaq next week with a pitch that reaches past the smart ring it is known for. The company has spent the past year turning the sleep, heart rate, temperature and stress signals its rings collect into personalized health guidance, rolling out a women’s health […] The post Oura’s IPO Puts AI-Powered…",
  "key_points": [
    "Oura launches IPO on Nasdaq, expanding beyond smart ring to AI-driven health insights",
    "Subscription revenue surges 121% to $240.5 million, with 5.7 million paid members by 2026"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}